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Gli proteins are transcriptional effectors of the
Hedgehog (Hh) pathway in both normal develop-
ment and cancer. We describe a program of
multisite phosphorylation that regulates the con-
version of Gli proteins into transcriptional activa-
tors. In the absence of Hh ligands, Gli activity
is restrained by the direct phosphorylation of
six conserved serine residues by protein kinase A
(PKA), a master negative regulator of the Hh
pathway. Activation of signaling leads to a global re-
modeling of the Gli phosphorylation landscape: the
PKA target sites become dephosphorylated, while a
second cluster of sites undergoes phosphorylation.
The pattern of Gli phosphorylation can regulate Gli
transcriptional activity in a graded fashion, suggest-
ing a phosphorylation-based mechanism for how a
gradient of Hh signaling in a morphogenetic field
can be converted into a gradient of transcriptional
activity.INTRODUCTION
The Hedgehog (Hh) pathway is an evolutionarily conserved
signaling system that plays a central role in embryogenesis
and adult tissue homeostasis. Itsmisregulation leads to develop-
mental defects and to cancers of the skin and the brain (Briscoe
and The´rond, 2013; Hahn et al., 1996). The Gli (Glioblastoma)
transcription factors in vertebrates control the Hh gene expres-
sion program (Hui and Angers, 2011). Despite the importance
of Gli proteins in development, regeneration, and cancer, the
mechanism by which they acquire the ability to activate target
genes has remained enigmatic.168 Cell Reports 6, 168–181, January 16, 2014 ª2014 The AuthorsAmong the three mammalian Gli proteins, Gli2 and Gli3 are the
first responders to the Hh signal. Once activated, Gli2/3 then
induce the expression of Gli1, which acts as an amplifier of the
response. Gli2/3 can perform two opposing functions at target
promoters (Figure 1A; reviewed in Hui and Angers, 2011).
When the pathway is off, Gli2/3 proteins are converted into trun-
cated repressor forms (hereafter abbreviated GliR), which inhibit
target gene transcription. When the Hh ligand is received, GliR
production is blocked and Gli2/3 proteins are converted into
transcriptional activators (hereafter abbreviated GliA). In the
nucleus, the balance between GliR and GliA shapes the Hh
response. Between these two extremes, a substantial fraction
of Gli2/3 remains in the cytoplasm in a transcriptionally inactive
state (Humke et al., 2010). Quantitative changes in the GliR/
GliA ratio can lead to developmental defects in humans, under-
scoring the point that the precise level of Gli activity is often
critical for the sophisticated patterning events regulated by Hh
signaling during development (Hill et al., 2007; Kang et al.,
1997; Wang et al., 2000).
GliR and GliA production are both controlled by the seven-
transmembrane protein Smoothened (Smo; Figure 1A). Upon
Hh ligand reception by Patched (Ptc), Smo accumulates in a
microtubule-based protrusion of the cell membrane known as
the primary cilium (Corbit et al., 2005). Through an unknown
mechanism, ciliary Smo inhibits GliR formation and induces the
transport of Gli proteins to the tips of cilia (Kim et al., 2009;
Wen et al., 2010), where they dissociate from the negative regu-
lator Suppressor of Fused (SuFu; Humke et al., 2010; Tukachin-
sky et al., 2010). Thereupon, Glis translocate into the nucleus and
activate target genes. Nuclear Gli proteins are characterized by a
short half-life and reduced mobility on SDS-PAGE gels caused
by a distinct phosphorylation event, hereafter referred to as
‘‘hyperphosphorylation’’ (Humke et al., 2010).
The mechanistic details of the interaction between Smo and
Gli proteins are not understood. Several lines of evidence point
to protein kinase A (PKA) as a key regulator of the Hh signal
Figure 1. PKA Phosphorylates Both Full and Partial Consensus Sites on Gli2/3 In Vitro
(A) Schematic representation of Gli2/3 regulation by Hh signaling. Active Smo induces the formation of GliA and suppresses the production of the truncated GliR.
(B) Location of the full (red dots; P1–6) and partial consensus (orange dots; Pa–o) PKA target sites that are conserved in both mouse and human Gli2 and Gli3.
(C) In vitro PKA phosphorylation of Myc-tagged Gli3 fragments containing the indicated target sites. An anti-myc immunoblot (top) shows total protein levels of
each fragment in the assay and the autoradiogram (bottom) shows 32P incorporation. The Pc-g (*) fragment was tested for both Gli3 and Gli2 since only the former
contains an additional PKA consensus target sequence.
(D) S/T residues presumed to be PKA targets weremutated in Gli3 fragments containing sites Pc-g, P1–4, P5,6, and Pm–o. Wild-type (W) or mutant (M) fragments
were subjected to in vitro phosphorylation as in (C).
(E) Protein sequences of Drosophila Ci, mouse Gli2, and Xenopus Gli3 were aligned using the Geneious algorithm and the degree of conservation of protein
sequences was plotted for either a 4-amino-acid or 15-amino-acid sliding window.downstream of Smo (Fan et al., 1995; Hammerschmidt et al.,
1996; Hynes et al., 1995; Jiang and Struhl, 1995; Lepage et al.,
1995; Li et al., 1995; Niewiadomski et al., 2013; Pan and Rubin,
1995; Strutt et al., 1995; Tuson et al., 2011). Pharmacological
activation of PKA completely blocks Hh signaling, even in the
presence of the Hh ligand or a Smo agonist. Conversely, genetic
ablation of PKA shifts the GliR/GliA balance strongly in favor of
GliA. This leads to full ligand-independent activation of Hh target
genes, manifested as complete ventralization of the embryonic
neural tube in mutant mice (Tuson et al., 2011). These data
clearly identify PKA as a negative regulator of Gli function, but
on a molecular level, our understanding of how Gli proteins are
influenced by PKA remains incomplete.
The mechanism by which PKA promotes GliR has been eluci-
dated in detail, guided by studies of the Drosophila Gli homolog
cubitus interruptus (Ci; Aza-Blanc et al., 1997; Me´thot and Basler,
1999;PriceandKalderon,1999;Wangetal., 1999).PKAcanphos-
phorylateGli2/3at six conservedserine residues (P1–6) locatedonCthe carboxyterminal side of the DNA binding Zn-finger domain
(Figure 1B; Wang et al., 2000). The phosphorylation of the first
four of these residues (P1–4) by PKA initiates a pathway that leads
to the partial processing of full-length Glis into GliR fragments by
the proteasome (Pan et al., 2009; Wang et al., 1999); the function
of the last two phosphorylation sites (P5,6) is unknown.
PKA plays an equally important but much less well-under-
stood role in suppressing Gli2/3A. Loss of phosphorylation at
sites P1–4, which regulates GliR production, does not seem to
be sufficient for this activation step. Transgenic mice harboring
nonphosphorylatable serine-to-alanine mutations in P1–4 of
Gli2 do not show the developmental phenotypes expected if
Gli2 was fully activated (Pan et al., 2009). Importantly, the neural
tube of these animals, in contrast to animals lacking PKA activity,
is not strongly ventralized. Thus, PKA must inhibit Gli2 activation
by phosphorylating sites other than P1–4.
Here, we elucidate the mechanism by which PKA inhibits the
production of GliA. PKA uses distinct phosphorylation patternsell Reports 6, 168–181, January 16, 2014 ª2014 The Authors 169
Figure 2. The P1–6 Cluster Regulates the
Balance between Gli3 Activator and Gli3
Repressor
(A) Location of sites P1–6 on mouse Gli2 and Gli3.
(B) An anti-HA immunoblot reveals the relative
levels of full-length and repressor Gli3 in whole-
cell extracts from NIH/3T3 Flp-In cells stably
expressing HA-tagged Gli3 variants.
(C) Distribution of full-length HA-Gli3 variants in
the nuclear (N) and cytoplasmic (C) fractions of
NIH/3T3 Flp-In cells left untreated or treated with
SAG (100 nM, 2 hr). In this and subsequent figures,
lamin A and tubulin serve as control nuclear and
cytoplasmic proteins to assess the quality of the
fractionation and bars above each blot represent
the relative abundance of HA-Gli3 in the cyto-
plasmic (gray) and nuclear (purple) fractions as
determined by quantitative immunoblotting. Fig-
ure S2B compiles data from five repeats of such
an experiment.
(D) Activation of a luciferase-based Hh reporter
gene in NIH/3T3 cells (untreated with any Hh
agonists) transiently transfected with the reporter
construct in combination with the indicated Gli3
variants. Values were normalized to reporter in-
duction seen with an empty plasmid (control).
Dashed gray line shows the level of reporter acti-
vation seen with SAG (100 nM; 24 hr) in cells
transfected with a control vector. See also Fig-
ure S2C. Error bars indicate SD from three inde-
pendent transfections.to regulate GliR and GliA; phosphorylation of P1–4 is sufficient
for GliR production, while the inhibition of GliA formation is
dependent on all six sites from the P1–6 cluster. Smo activation
reduces phosphorylation of P1–6, showing that Hh signaling
wields direct control over phosphorylation at these sites. We
also find that P1–6 dephosphorylation allows the phosphoryla-
tion of Gli2 at a distinct cluster of sites, which plays a positive
role in Hh signaling. We propose that remodeling of the phos-
phorylation landscape of Gli2/3 proteins controls the transcrip-
tional output of Hh signaling and discuss the implications of
this model for the role of Hh as a morphogen in development.
RESULTS
PKA Phosphorylates Gli2/3 at Multiple Sites In Vitro
Previous work has implicated PKA both in GliR formation and in
GliA inhibition (Hammerschmidt et al., 1996; Pan et al., 2009;
Tuson et al., 2011; Wang et al., 1999, 2000), but the biochemical
mechanism by which PKA blocks GliA formation was unknown.
We hypothesized that PKA suppresses the formation of GliA by
direct phosphorylation of Gli2/3. In order to identify putative
inhibitory PKA target sites onGli2/3, we looked for full consensus
sites (R or K present at positions 2 and 3 from the S or T) and
partial consensus sites (R or K only present at either position 2
or position 3 from the S or T) that were conserved among
human and mouse Gli2 and Gli3 and were located outside the
DNA-binding zinc finger domain (Figure S1A). In addition to the170 Cell Reports 6, 168–181, January 16, 2014 ª2014 The Authorsfull consensus sites (P1–6) described previously (Pan et al.,
2009; Price and Kalderon, 1999; Wang et al., 2000), we identified
15 partial consensus sites (hereafter called Pa–o; Figures 1B and
S1B). Myc-tagged fragments of Gli3 containing various subsets
of these sites were tested as PKA substrates using an in vitro ki-
nase assay. Four fragments containing sites P1–4, P5,6, Pc–g,
and Pm–o could be phosphorylated by PKA (Figures 1C and
1D). Interestingly, both the P1–6 and the Pc–g clusters are
located in regions of Gli2/3 that are strongly conserved among
the Drosophila, Xenopus, and mouse proteins (Figure 1E).
PKA Target Sites P1–6 Regulate Gli3 Repressor and
Activator Functions
We first analyzed the six sites in the P1–6 cluster, which had pre-
viously been identified as PKA targets (Riobo´ et al., 2006; Wang
et al., 2000; Figure 2A). We decided to study P1–6 in the context
of bothGli3 andGli2, sinceGli3 is themajor repressor (Gli3R) and
Gli2 the major activator (Gli2A) in most tissues. To understand
the role of specific sites within the P1–6 cluster in regulating
the GliR/GliA balance, we made nonphosphorylatable alanine
mutants of P1–4 (P1–4A), P5 and P6 (P5,6A), or of the entire
P1-6 cluster (P1–6A) in Gli2 and Gli3. Since Gli proteins fail to
be regulated byHh signaling when overproduced in cells (Humke
et al., 2010), we sought to evaluate these Gli mutants under
endogenous expression levels. To that end, we stably expressed
hemagglutinin (HA)-tagged Gli2/3 (HA-Gli2/3) mutants in NIH/
3T3 fibroblasts using the Flp-In system, in which an expression
construct is introduced as a single-copy insertion into a defined
locus in the genome by Flp-mediated recombination (Torres
et al., 2009; Zhou et al., 2010). The Flp-In system allowed us to
rapidly generate stable cell lines expressing Gli protein variants
at near-endogenous (Figure S2A) and roughly equal (Figure 2B)
levels.
Starting with Gli3, we verified that a wild-type (WT) HA-Gli3
behaved like its endogenous counterpart. Indeed, HA-Gli3(WT)
could be processed into a HA-GliR fragment when expressed
using the Flp-In system (Figure 2B). Consistent with previous re-
ports (Pan et al., 2006, 2009; Tempe´ et al., 2006; Wang and Li,
2006), mutation of sites P1–4 into alanine was sufficient to block
Gli3R formation, as neither Gli3(P1–4A) nor Gli3(P1–6A) was con-
verted into Gli3R. In contrast, Gli3(P5,6A) readily formed Gli3R in
unstimulated cells (Figure 2B). Prior reports have implicated all
six sites in the P1–6 cluster in GliR formation (Wang et al.,
2000), but these studies were based on transient Gli3 overex-
pression and required stimulation with high doses of forskolin
for prolonged periods of time to produce Gli3R. Using experi-
mental conditions that faithfully reflect endogenous Gli3 pro-
cessing in untreated cells, we find that sites P5 and P6 are not
involved in the PKA-dependent truncation of Gli3 into a repressor
fragment.
The formation of Hh-induced Gli3A can be experimentally fol-
lowed by two biochemical events: activated Gli3 translocates
into the nucleus and undergoes hyperphosphorylation, which
appears as a shift in the apparent molecular weight of Gli pro-
teins on SDS-PAGE gels (Humke et al., 2010). As we have previ-
ously described for endogenous Gli3, treatment of cells with the
Smo agonist SAG led to the redistribution of HA-Gli3(WT) into the
nuclear fraction; nuclear HA-Gli3 also showed the characteristic
reduction in electrophoretic mobility indicative of hyperphos-
phorylation (Figure 2C, top panel, and Figure S2B). In contrast,
when all six of the P1–6 sites were simultaneously mutated to
alanines, Gli3 accumulated to high levels in the nucleus even in
the absence of Hh signaling (Figure 2C, middle panel, and Fig-
ure S2B). Saturating concentrations of SAG did not further in-
crease the nuclear accumulation of HA-Gli3(P1–6A), showing
that the mutation of these six residues makes Gli3 unresponsive
to upstreamHh signals. Alaninemutations only in sites P5 andP6
increased levels of Gli3 in the nucleus seen in the absence of
signaling but did not result in maximal nuclear accumulation;
HA-Gli3(P5,6A) still moved to the nucleus in response to SAG
(Figure 2C, bottom panel, and Figure S2B).
To measure transcriptional activity of the Gli3 mutants, we
transiently transfected constructs encoding each protein and
measured the activation of an Hh-dependent firefly luciferase re-
porter gene (Sasaki et al., 1997). Consistent with prior character-
ization of Gli3 as a weak transcriptional activator (Sasaki et al.,
1997), both HA-Gli3(WT) and HA-Gli3(P1–4A) failed to substan-
tially increase Hh-dependent luciferase expression. On the other
hand, HA-Gli3(P1–6A) could activate the reporter gene (Fig-
ure 2D), confirming the role of P5 and P6 in limiting the ability
of Gli3 to activate transcription. Neither HA-Gli3(P1–4A) nor
HA-Gli3(P1–6A) could be processed to Gli3R (Figure 2B), and
so differences in their ability to activate transcription cannot be
attributed differences in Gli3R levels. All six sites in the P1–6
cluster play a role in tuning Gli3 activity, since HA-Gli3(P5,6A)Calso demonstrated low levels of transcriptional activity, analo-
gous to that of HA-Gli3(P1-4A) (Figure S2C).
These results suggest that Gli3 may be regulated by graded
dephosphorylation. Loss of P1–4 phosphorylation blocks Gli3R
repressor formation but is insufficient for the full activation of
Gli3. The additional loss of P5,6 phosphorylation is required to
achieve complete transformation of Gli3 into Gli3A.
Sites P1–6Determine the Transcriptional Activity of Gli2
Since Gli2 is the major transcriptional activator of Hh target
genes in most tissues, we made a similar series of mutations in
the P1–6 sites of Gli2. While WT HA-Gli2 can activate the Hh re-
porter in transient overexpression assays (Figure 3A; Sasaki
et al., 1999), the Gli2(P1–6A) mutant was significantly more
active at all doses tested. The P1–4A and P5,6A mutants of
Gli2 showed an intermediate capacity to activate the reporter.
Mutation of either P5 or P6 individually in combination with
P1–4 also increased activity of Gli2, suggesting that P5 and P6
may be partially redundant (Figure S2D). Conversely, mutation
of both sites P5 and P6 to aspartate (P5,6D), a phospho-mimetic
mutation, substantially reduced the activating potential of Gli2
(Figure S2D). These results are consistent with an inhibitory
role of P1–6 phosphorylation in the activation of Gli2.
To examine Gli2 regulation under physiological expression
levels, we turned to Flp-In stable lines carrying HA-tagged Gli2
mutants (Figure S2A). Similar to its effect on Gli3, the P1–6A
mutation in HA-Gli2 caused constitutive Hh-independent accu-
mulation in the nucleus, consistent with Gli2(P1–6A) being a fully
active molecule (Figure 3B). In order to correlate nuclear accu-
mulation with transcriptional activity, we measured the expres-
sion of endogenous Gli1, a Hh target gene commonly used as
a metric for pathway activity, in these same stable cell lines. In
the absence of Hh signaling, Gli1 levels were not elevated in
the line expressing HA-Gli2(WT), confirming that this exogenous
protein is properly regulated (Figure S2E). To account for differ-
ences in expression levels of the HA-Gli2 variants (Figure 3C), we
compared their specific activities, calculated as the level of Gli1
induction divided by the protein level of the corresponding
HA-Gli2 variant. The specific activities of the mutants fell along
a gradient: the HA-Gli2(P1–4A) and HA-Gli2(P5,6A) mutants
demonstrated 3- to 4-fold higher specific activity and the HA-
Gli2(P1–6A) mutant displayed 13-fold higher specific activity
compared to HA-Gli2(WT) (Figure 3C). The high level of Gli1 in
cells carrying Gli2(P1–6A) was resistant to inhibition by two
Smo antagonists, cyclopamine and SANT-1 (Figures 3D and
S2F), demonstrating that the activity of this mutant protein was
independent of Smo. Importantly, all the stable cell lines (which
also contain endogenous Gli2) were able to produce equivalent
levels of Gli1 when stimulated with SAG, showing that they did
not differ in their intrinsic capacity to activate Hh targets (Fig-
ure 3C). Since the Flp-In lines also expressed endogenous
Gli2, the GLI1 induction in response to SAG (Figure 3C) could
not be used to infer the Hh-responsiveness of the HA-Gli2 vari-
ants expressed in these lines.
To analyze the ability of upstream Hh signaling to regulate the
HA-Gli2 mutants in our Flp-In cell lines, we selectively depleted
endogenous Gli2 with a small interfering RNA (siRNA) directed
against its 30 UTR (Figures 3E and S2G). Under these conditions,ell Reports 6, 168–181, January 16, 2014 ª2014 The Authors 171
Figure 3. The P1–6 Cluster Regulates the
Activation of Gli2
(A) Luciferase reporter activity in NIH/3T3 cells
(untreated with any Hh agonists) transiently
transfected with the indicated Gli2 variants. The
dashed line shows levels of reporter induction
seen when cells transfected with a control vector
are exposed to SAG (100 nM). Error bars denote
SD from three independent transfections.
(B) Distribution of full-length HA-Gli2 in NIH/
3T3 Flp-In cells stably expressing the indicated
variants.
(C) Levels of the Hh target gene Gli1 and HA-Gli2,
measured using anti-Gli1 and anti-HA immuno-
blots respectively, in NIH/3T3 Flp-In stable cell
lines expressing the indicated Gli2 variants. Cells
were left untreated or treated with SAG (100 nM,
24 hr). Bar charts underneath show quantitation of
the Gli1 and HA-Gli2 proteins (normalized to
tubulin) in each cell line and the specific activity of
each variant (top chart), expressed as the ratio of
the intensities of the Gli1 band to the HA band.
Bars denote the mean (±SD) from two indepen-
dent experiments.
(D)Gli1mRNA level, measured by quantitative RT-
PCR, in Flp-In stable cell lines expressing the
indicated HA-Gli2 variants. HA-Gli2(P1-6A) cells
were left untreated or treated with the Smo in-
hibitors cyclopamine (5 mM) or SANT-1 (100 nM).
The Gli1 mRNA level was normalized to the HA-
Gli2 protein level as in (C) to adjust for differences
in expression level of the Gli variants. Bars denote
the mean (±SD) from two independent samples.
(E)Gli1mRNA level in the indicated stable cell lines
treated with SAG (100 nM) in the presence or
absence of the PKA activators IBMX (100 mM) and
FSK (0.1 mM). In all cells, expression of endoge-
nous Gli2 was reduced by a siRNA directed
against the 30 UTR to examine signaling through the HA-Gli2 variants. TheGli1mRNA level was normalized to HA-Gli2 protein measured as in (C) and (D); graphs
depicting data without the HA-Gli2 protein normalization are shown in Figures S2F and S2G. Bars denote the mean (±SD) from two independent samples.the SAG initiated signal should be largely transduced through our
HA-tagged Gli2 variants. In the absence of endogenous Gli2,
SAG could significantly increase Gli1 expression in either HA-
Gli2(WT) or HA-Gli2(P1–4A) cells. In the same cell lines, PKA acti-
vation, accomplished with the drugs isobutylmethylxanthine
(IBMX) and forskolin (FSK) antagonized the effect of SAG (Fig-
ure 3E). In contrast, the high baseline expression of Gli1 in the
HA-Gli2(P1–6A) line was largely insensitive to regulation by either
SAG or IBMX/FSK (Figures 3E and S2G). This is further evidence
that Gli2(P1–6A) corresponds to a maximally active form of Gli2,
which cannot be regulated by either Smo or PKA. Gli2(P1–4A) re-
mains SAG and PKA sensitive, perhaps through phosphoregula-
tion at the P5 and P6 sites. We conclude that only after losing all
phosphates at sites P1–6 does Gli2 become a bona fide GliA.
These data explain why the previously studied Gli2(P1–4A)
mutant of Gli2 failed to fully activate Hh responses during devel-
opment (Pan et al., 2009).
P1–6 Mutants of Gli2 Ectopically Specify Ventral Cell
Types in the Developing Spinal Cord
Encouraged by these results, we tested the ability of Gli2(P1–6A)
to drive Hh-regulated cell fate decisions in vivo in a cell-autono-172 Cell Reports 6, 168–181, January 16, 2014 ª2014 The Authorsmous manner. In the ventral neural tube, Shh acts as a graded
signal that specifies the dorsal-ventral pattern of progenitor sub-
types (Figure 4A). This precise spatial patterning is established
by a gradient of Gli activity (Bai et al., 2004; Lei et al., 2004; Sta-
mataki et al., 2005), making the neural tube an ideal place to test
the activities of our Gli2(P1–4A) and Gli2(P1–6A) mutants. Using
in ovo electroporation techniques, we expressed the Gli2
mutants under the control of a weak SV40 early promoter in
one-half of the neural tube of Hamburger-Hamilton (HH) stage
10–12 chicken embryos and examined the expression of various
progenitor markers 48 hr later. Ectopic expression of Gli2(WT)
did not alter the spatial arrangement of neuronal progenitors
(Figures 4B–4D, top row, and Figure S3C) and also did not
induce expression of PTCH1, a direct Hh target gene (Figure 4E,
top row).
In contrast, overexpression of Gli2(P1–6A) at any position
along the dorsoventral axis led to the ectopic specification of
ventral cells, identified by the ventral-most progenitor domain
(pFP/p3) marker FOXA2 and the p3 marker NKX2.2, both of
which depend on the highest levels of Hh/Gli signaling (Figure 4B,
bottom row, and Figure S3C). Gli2(P1–6A) could also induce
NKX6.1, which labels the pFP, p3, pMN, and p2 progenitor
Figure 4. Gli2(P1-6A) Can Induce Ventral Cell Fates in the Developing Spinal Cord
(A) A schematic illustrating the relationship between marker proteins and progenitor cell populations in the embryonic neural tube (adapted from Stamataki et al.,
2005). pFP, floor plate progenitors; pMN, motor neuron progenitors; p0, p1, p2, p3, ventral interneuron progenitors.
(B–D) Constructs encoding Gli2 variants (green) were electroporated into developing spinal cords of chicken embryos. Expression of the indicated progenitor
population markers (red) was detected by immunofluorescence 48 hr later. Black and white panels show marker expression in both sides of the spinal cord
(‘‘+’’ indicates the electroporated side, ‘‘’’ the unelectroporated side). Overlay panels show the electroporated side only. See also Figure S3C.
(E) In situ hybridization for PTCH1 mRNA in sections of spinal cord electroporated with the indicated Gli2 constructs. The right side of each section was elec-
troporated.
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domains. OLIG2, a marker of motor neuron progenitors (pMN),
which are specified by intermediate levels of Hh signaling, was
induced mostly in cells expressing lower levels of Gli2(P1–6A)
but often suppressed in strongly Gli2(P1–6A)-positive cells,
most likely reflecting the cross-repressive interaction between
NKX2.2 andOLIG2 in the neural tube (Novitch et al., 2001). More-
over, Gli2(P1–6A) suppressed the expression PAX6, a dorsal
marker known to be negatively regulated by Hh signaling.
Consistent with this ability to specify cell fates that depend on
high levels of Hh ligand, Gli2(P1–6A) induced the robust expres-
sion of PTCH1, a direct Hh target gene, throughout the neural
tube. The ability Gli2(P1–6A) to induce the ventral and suppress
the dorsal markers was resistant to coexpression of a constitu-
tively active mutant of Patched, PtchDloop2 (Briscoe et al.,
2001), confirming that the P1–6A mutant of Gli2 escapes regula-
tion by the upstream elements of the Hh pathway (Figure S3A).
Gli2(P1–4A) demonstrated intermediate activity: it induced
FOXA2, NKX2.2, and NKX6.1when expressed immediately adja-
cent to their normal domains but not when expressed in more
dorsal regions of the neural tube (Figures 4B–4D, middle row,
and Figure S3C). This expansion of the ventral domains suggests
that Gli2(P1–4A) sensitized cells to Shh, such that the same level
of Shh exposure is translated to more ventral cell fates. Even
though our Gli2 variants induced ectopic FOXA2, they did not
drive SHH expression (Figure S3B), suggesting that the effects
we describe in Figure 4 were not due to non-cell-autonomous
effects of ectopic floor plate induction in the electroporated spi-
nal cords. These data are consistent with previous reports
showing that activated Smo and Gli proteins expressed in the
HH12 stage neural tube can promote ventral character while at
the same time inhibiting the formation of floor-plate cells (Lei
et al., 2004; Ribes et al., 2010). Neither Gli2 mutant affected
the expression of Hh-independent progenitor markers SOX2
and NGN2, suggesting that the total number of neuronal pro-
genitors is unchanged by the expression of these constructs
(Figure S3B).
Taken together, these data suggest that there is a fundamental
difference between blocking phosphorylation at sites P1–4 only
and blocking it throughout the P1–6 cluster. Because both the
P1–4A and P1–6A mutations block repressor formation (Fig-
ure 2B), the marked differences in the activities of Gli2(P1–4A)
and Gli2(P1–6A), both in cultured cells and in the developing
neural tube, must be attributed to the role of P5 and P6 in theFigure 5. Phosphorylation of the P1–6 Sites Declines with Hh Signaling
(A) Measurement of phosphopeptide abundance using SRM. Peptides were mon
Flp-In cells or in cells treated for 4 hr with 100 nM SAG, both in the presence o
transition for two peptides, a nonphosphorylatable peptide used as a loading c
retention time (XIC, extracted ion current; gray trace). Blue traces are XICs of the
digest before the run. For each condition, the normalized abundance of a pepti
(endogenous) peptide to the AUC for the heavy peptide.
(B) XIC versus retention time plots showing three SRM transitions for each of the e
(C and D) Normalized abundance of phosphopeptides (calculated using an SRM
from tryptic digests of immunopurified Gli2 isolated from NIH/3T3 cells treated
abundance measured in cells after PKA activation with IBMX + FSK was taken a
independent MS runs.
(E and F) Phosphopeptide abundance wasmonitored as a function of time after SA
levels of Gli3 (E) or Gli2 (F) in the nucleus (blue line). Percent of total Gli in the nucle
Figure 2C (Humke et al., 2010).
Cformation of Gli2A. Dephosphorylation of these sites in response
to Hh ligands appears to be necessary to unleash the full activa-
tion potential of Gli2. P6 phosphorylation has been previously
implicated in the interaction of Glis with 14-3-3 proteins (Asaoka
et al., 2010), but in our system, this interaction did not appear to
be required for the inhibitory function of P6 in GliA formation (see
Supplemental Discussion and associated Figures S6B and S6C).
Hh Signaling Reduces Phosphorylation of P1–6
Our mutagenesis studies suggested that loss of phosphorylation
on the serine residues at P1–6 is a regulatory step in the activa-
tion of Gli proteins. Hence, we sought to monitor changes in the
phosphorylation status of these sites on endogenous Gli2 in
response to signaling. Wewere unable to raise phospho-specific
antibodies that recognized multiple sites on endogenous Gli2 in
a quantitative fashion. Instead, we developed a mass spectrom-
etry (MS)-based selected reaction monitoring (SRM) assay to
quantitatively assess phosphate occupancy at P1, P2, P5, and
P6 (Cox et al., 2005; Gerber et al., 2003; Mayya et al., 2006).
Endogenous Gli2, isolated by immunoaffinity purification, was
digested with trypsin, and the phosphorylated versions of the
tryptic peptides encompassing sites P1, P2, P5, and P6 were
quantified by triple-quadrupole MS (Figure 5A).
Activation of Hh signaling by SAG reduced the abundance of
phosphorylated peptides containing sites P1, P2, P5, and P6
(Figures 5B and 5C), with changes at P5 and P6 being more
marked than those in sites P1 and P2. The phosphorylation of
sites P5 and P6 was sensitive to both the concentration of
SAG and the duration of SAG treatment (Figures 5E and 5F). In
both cases, reduction in phosphorylation correlated with the
amount of Gli in the nucleus. The changes in Gli2 phosphoryla-
tion were not due to differences in protein stability, since all
measurements were conducted on cells pretreated with the
proteasome inhibitor bortezomib and results obtained in the
absence and presence of this drug were similar (Figures 5C
and S4A). In addition, no changes were observed after SAG
addition in the abundance of a control, nonphosphorylatable
peptide from a different region of Gli2 (Figure 5A). A caveat
with measuring dephosphorylation by quantitative MS is that
the observed reduction in the abundance of a phosphopeptide
might reflect a change in phosphate occupancy of nearby sites
rather than actual dephosphorylation of the site of interest. To
address this concern, we alsomonitored the nonphosphorylateditored in tryptic digests of immunoprecipitated Gli2 either in untreated NIH/3T3
f the proteasome inhibitor bortezomib (1 mM). The intensity of the ‘‘strongest’’
ontrol (left) and a phospho-P6-containing peptide (right), was plotted versus
corresponding heavy isotope-labeled standard peptide spiked into the tryptic
de was calculated as the ratio of the area under the curve (AUC) for the light
ndogenous (light) phosphorylated peptides containing sites P1, P2, P5, and P6.
assays of the kind shown in A) containing the P1, P2, P5, and P6 sites derived
(4 hr) with SAG (100 nM) or IBMX (100 mM) + FSK (100 nM). Phosphopeptide
s maximal (100%) phosphorylation. Bars denote means (±SD) of two to three
G treatment (E) and as a function of SAG concentration (F) and compared to the
us was calculated based on subcellular fractionation experiments as shown in
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peptide encompassing site P6 (dephospho-P6) by SRM and
observed that its abundance rose with SAG treatment and
declined with IBMX and FSK (reciprocal to the pattern seen
with phospho-P6; Figure S4B), suggesting that the changes in
phospho-P6 were due to bona fide dephosphorylation of the
P6 site.
Stimulation of PKA activity with IBMX and FSK strongly
increased phosphate occupancy at all sites within the P1–6 clus-
ter and also prevented SAG from decreasing phosphorylation
(Figure 5D). This result is consistent with the model that PKA
negatively regulates Hh signaling by phosphorylating P1–6. It
also suggests that even in resting cells, Gli proteins are not fully
phosphorylated at the P1–6 sites. The reason why these partially
dephosphorylated Glis do not become transcriptionally active is
unknown but may be related to the dynamics of the phosphate
turnover on individual sites within the cluster. For instance, there
may be some redundancy between individual sites in the P1–4
and P5,6 clusters.
A Cluster of Serine/Threonine Sites Is Important for
Gli2/3 Activation
Since phosphorylation of the P1–6 cluster seemed sufficient for
the inhibition of GliA formation, we were curious to determine
how the two remaining clusters of putative PKA target sites
(Pc–g, Pm–o; Figures 1B and 1C) affected Gli function. Alanine
mutations in Pm–o cluster did not have a discernable effect (Fig-
ure S5A) in our assays, so we focused on the Pc–g cluster. To
explore the role of Pc–g phosphorylation in the regulation of
Gli2, we made both nonphosphorylatable and phosphomimetic
mutations of this cluster in Gli2, replacing the serine and threo-
nine residues with alanine or glutamate [hereafter called
Gli2(Pc–gA) and Gli2(Pc–gE)]. In Hh reporter assays, HA-
Gli2(Pc-gE) was significantly more active than the WT protein
(Figure 6A) and Gli2(Pc–gA) was approximately 40% less active
than the WT protein (Figure 6B). We also generated cell lines
stably expressing HA-Gli2(Pc–gE) using the Flp-In system.
Gli2(Pc–gE) protein levels were lower than Gli2 (WT), suggesting
that the mutant protein was less stable (Figure S5B). The higher
specific activity of HA-Gli2(Pc–gE) (Figure 6C) supported the
model that Pc–g phosphorylation, in contrast to P1–6 phosphor-
ylation, plays a positive role in Gli2 activity. Gli2(Pc–gE) also
showed other hallmarks of activation, including reduced mobility
on a gel and higher levels in the nucleus (Figure 6D).
Hh Signaling Promotes and PKA Antagonizes
Phosphorylation on Pg
The characterization of Pc–g phosphorylation as playing a posi-
tive role in Gli activity was inconsistent with our initial identifica-
tion of these sites as in vitro targets for PKA (Figure 1), a kinase
that has an inhibitory effect on Hh signaling in vertebrates
(Epstein et al., 1996; Humke et al., 2010; Tukachinsky et al.,
2010; Tuson et al., 2011). To monitor Pc–g phosphorylation in
the context of endogenous Gli2 in cells, we established an
SRM assay to measure levels of a phosphorylated tryptic pep-
tide that encompassed Pg, the only site in the Pc–g cluster
whose phosphorylation could be easily monitored by MS (Table
S1). Surprisingly, in cells treated with FSK and IBMX to activate
PKA, Pg phosphorylation was reduced (Figure 6E), demon-176 Cell Reports 6, 168–181, January 16, 2014 ª2014 The Authorsstrating that the Pg site is not a bona fide PKA target in cells.
Instead, we observed a 5-fold increase in the abundance of
phosphorylated Pg upon SAG treatment (Figure 6E), supporting
themutational data pointing to a positive role for Pc-g phosphor-
ylation in Gli2 activity. As for P6, we also monitored the abun-
dance of a nonphosphorylated tryptic peptide encompassing
site Pg (dephospho-Pg; Figure S5C). As expected, dephos-
pho-Pg abundance dropped with SAG treatment and increased
with IBMX + FSK treatment, providing further evidence for the
positive regulation of Pc–g phosphorylation by the Shh signal.
Experiments performed in the presence and absence of a pro-
teasome inhibitor gave qualitatively similar results (Figure S5D).
Interestingly, both the temporal dynamics and SAG dose-
sensitivity of Pc–g phosphorylation (Figures 6F and 6G) mirrored
those of P1–6 dephosphorylation (Figures 5E and 5F). PKA acti-
vation had opposite effects on the phosphorylation of the Pc–g
and P1–6 clusters, suppressing the former while promoting the
latter (Figures 6E and 5D). A parsimonious interpretation of these
data is that PKA prevents Pc–g phosphorylation and Gli activa-
tion by directly phosphorylating the P1–6 sites.
To dissect the hierarchy between the Pc–gE and P1–6 sites,
we combined activating (Pc–gE) and inhibitory (Pc–gA) muta-
tions in the Pc–g sites with either inactivating (P5,6D) or
activating (P1–6A) mutations in the P1–6 sites (Figure 6H). In
Hh reporter assays, the activities of the Gli2(Pc–gE/P5,6D)
and Gli2(Pc–gE/P1-6A) combination mutants were very similar,
demonstrating that activating modifications at Pc–g make the
phosphorylation status of P1–6 irrelevant. Controls confirmed
that the isolated P5,6D mutation is much less active than
the P1–6A mutant. Conversely, introduction of the inactivating
Pc–gA mutation into Gli2(P1–6A) caused a substantial drop in
its constitutive activity both in transient transfection assays (Fig-
ure 6I) and in a stable cell line (Figure 6J). These results support
themodel that Pc–g phosphorylation is an activating event gated
by PKA-regulated phosphorylation of the P1–6 sites.
DISCUSSION
Distinct Phospho-codes for Gli Activator and Gli
Repressor Regulation
We show here that phosphorylation of Gli proteins at six PKA
target sites (P1–6) is a central determinant of their transcriptional
activity, controlling the production of both repressor (GliR) and
activator (GliA) forms. Our data are most consistent with a model
involving ordered changes of phosphate occupancy at sites
located in two distinct serine/threonine clusters (Figure 7A). In
resting cells, PKA phosphorylates sites P1–6 on Gli2/3,
triggering proteasomal processing into GliR and blocking
conversion into GliA. When Hh binds to Ptc, Smo inhibits P1–6
phosphorylation, initiating a pathway that ultimately leads to
the production of GliA: Gli proteins undergo phosphorylation at
the Pc–g cluster, enter the nucleus, and are converted to unsta-
ble transcriptional activator proteins. We propose that the full
transcriptional activation of Gli proteins requires the loss of
phosphates at the P1–6 cluster followed by the gain of phos-
phates at the Pc–g cluster. The relative ordering of these
two events is demonstrated by the fact that PKA activation en-
hances P1–6 phosphorylation and blocks Pc–g phosphorylation
Figure 6. Pc–g Phosphorylation Positively Regulates Gli2 Activity
(A and B) Hh reporter activity in NIH/3T3 cells transiently transfected with Gli2(WT), Gli2(Pc-gA) or Gli2(Pc-gE). Bars are mean (±SD) of two independent
transfections.
(C and D) NIH/3T3 Flp-In cell lines expressing HA-Gli2(WT) or HA-Gli2(Pc-gE) were used to evaluate the specific activity (C, analyzed as in Figure 3C) and
subcellular distribution (D, analyzed as in Figure 2C) of the Gli2 variants. Bars are mean (±SD) of three independent experiments.
(E) XIC versus retention time traces for three SRM transitions derived from a Gli2 tryptic phosphopeptide containing the Pg residue. Phosphopeptide abundance
is compared for Gli2 immunopurified from cells treated with the indicated drugs (4 hr).
(F and G) Pg phosphorylation abundance as a function of the concentration of SAG (F) or the duration of SAG exposure (G).
(H) Hh reporter activity in NIH/3T3 cells transiently transfected with Gli2(WT), Gli2(P5,6D), Gli2(P1–6A), and the combined mutants Gli2(Pc–gE/P1–6A) and
Gli2(Pc–gE/P5,6D). Bars are mean (±SD) of three independent transfections.
(I) Hh reporter activity in NIH/3T3 cells transiently transfected with Gli2(WT), Gli2(Pc–gA), Gli2(P1–6A), and the combinedmutant Gli2(Pc–gA/P1–6A). Bars denote
mean ± SD from two independent transfections.
(J) Level of the Hh target gene Gli1 measured using anti-Gli1 immunoblot in cell lines stably expressing near-endogenous levels of the indicated HA-Gli2 con-
structs. Bar chart shows quantitation of Gli1 protein normalized to lamin.
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Figure 7. Our Model for the Phosphoregulation of Gli Proteins in Hh
Signaling
(A) Diagram illustrating the multisite phosphorylation model of Gli2/3
regulation.
(B) Multiple states of Gli activity can be encoded by different patterns of Gli
phosphorylation at the P1–6 cluster. Full phosphorylation of P1–6 (left) drives
GliR formation and blocks GliA formation. Partially dephosphorylated Gli
proteins (middle) function as weak activators and may be able to form GliR,
depending on the pattern of phosphorylation. Fully dephosphorylated Gli
proteins (right) cannot form GliR and function as strong transcriptional acti-
vators. See also Supplemental Discussion.(Figure 6E). This regulatory motif, a gating dephosphorylation
event coupled to nuclear translocation and an activating phos-
phorylation event at a distinct site, is reminiscent of the mecha-
nism by which nuclear factor of activated T cells (NFAT) is
regulated in response to T cell receptor engagement (Okamura
et al., 2000). The concerted dephosphorylation of 13 phospho-
serine residues by the phosphatase calcineurin triggers a confor-
mational change in NFAT that drives nuclear localization. Like the
Gli proteins, NFAT also requires an activating phosphorylation
event at a separate site to acquire full transcriptional activity.
Interestingly, in Gli1, which acts as a strong constitutive acti-
vator, the P1–6 cluster is poorly conserved (only sites P1, P2,
and P6 show some degree of conservation). By contrast, four
out of the five sites in the Pc–g cluster, including Pg, show
remarkable sequence conservation among the threemammalian
Gli proteins. This suggests that Pc–g phosphorylationmay act as
a universal activating signal for the Gli family.
Many signaling pathways, such as the NFAT pathway, regu-
late the conversion of a transcription factor from an inactive to
an active state. The Hh pathway is different in that it controls178 Cell Reports 6, 168–181, January 16, 2014 ª2014 The Authorsthe balance between gene repression, mediated by GliR, and
gene activation, mediated by GliA. For instance, in Drosophila,
low levels of Hh signaling suppress the formation of CiR, but
higher levels are required for the production of CiA (Me´thot and
Basler, 1999, 2001). Our analysis of the P1–6 cluster in Gli3 (Fig-
ure 2) suggests that repressor and activator functions of Gli pro-
teins can be encoded by different patterns of phosphorylation:
loss of phosphates at P1–4 is enough to block repressor forma-
tion, but loss of phosphates at all six P1–6 residues is needed for
full nuclear translocation and transcriptional activity (Figure 7B).
This provides a simple mechanism by which signaling can exert
independent control over the repressor and activator functions
of Gli2/3.
While repressors forms of the Gli proteins can be assayed
directly due to their truncated length, a reliable biochemical
mark for Gli activator formation has remained elusive. GliA for-
mation has been inferred indirectly from changes in subcellular
localization, such as nuclear translocation, or from target gene
activation. This is a clinically relevant issue, since such a mark
of Gli protein activity would be a valuable predictive biomarker
for patients being considered for Hh antagonists, and could be
used as a pharmacodynamic parameter to assess responses.
Our SRM MS analysis suggests that Pg phosphorylation can
serve as such a marker for Gli2 activity.
Graded Control of Gli Activity by Multisite
Phosphorylation
Why might Gli proteins be regulated through such a complex
phosphorylation scheme? Multisite phosphorylation is a com-
monly used regulatory module in diverse signaling systems (re-
viewed in Salazar and Ho¨fer, 2009). It can be used to engineer
an ultrasensitive ON/OFF switch or to encode a rheostat, allow-
ing graded responses to varying signal strength. Examples of the
latter include graded enhancement of p53 binding to CREB in
response to genotoxic stress (Lee et al., 2010), graded binding
of Ets-1 to DNA (Pufall et al., 2005), and graded regulation of
the gating properties of the Kv2.1 potassium channel (Park
et al., 2006). In fact, a theoretical model has shown that multisite
phosphorylation may serve to refine such a rheostat by allowing
multistability, the existence of multiple discrete activity states in
the target protein or signaling module (Thomson and Gunawar-
dena, 2009). A multistable rheostat would be well adapted to
the function that Gli proteins serve during embryonic develop-
ment. In developmental fields such as the limb, the inner ear,
and the neural tube, Hh ligands function as classical morpho-
gens, and a central task of signaling is to translate ligand
exposure into discrete outputs, such as cell fate, at the level
of transcription (Bai et al., 2004; Bok et al., 2007; Fuccillo
et al., 2004; Stamataki et al., 2005). Multisite phosphorylation
might provide one mechanism by which differences in signal
strength are converted into multiple discrete states of Gli activity
(Figure 7B).
Indeed, our mutant analysis of the P1-6 cluster in Gli2 (Figures
3 and 4) is not consistent with a model in which Gli2 exists in
either a fully inactive or fully active state. Particularly pertinent
is the observation that both the P5,6A and the P1–4A mutants
of Gli2 show an intermediate intrinsic capacity for transcriptional
activation, which is higher than that of the WT protein but
significantly lower than that of the P1–6A mutant. Thus, Gli2 may
occupy multiple states with differing activity, states that could
represent different conformations of Gli2 that are stabilized by
different patterns of phosphorylation at the P1–6 and Pc-g clus-
ters. An important question going forward will be to ascertain
how these changes in phosphate occupancy at the two
conserved serine/threonine clusters affect the ability of Gli pro-
teins to interact with other proteins in the cytoplasm, the cilium,
and the nucleus and how these changes ultimately shape the Hh
transcriptional program (also see Supplemental Discussion).
EXPERIMENTAL PROCEDURES
Cell Culture
293T cells, NIH/3T3 cells, and NIH/3T3 Flp-In cells (Life Technologies),
including derivative stable clones, were cultured in media composed of
Dulbecco’s modified Eagle’s medium (high glucose), 10% fetal bovine
serum (FBS; Thermo Fisher Scientific), 13 GlutaMAX, 13 nonessential amino
acids, 13 sodium pyruvate, and 13 penicillin/streptomycin (all from Life Tech-
nologies). Prior to harvesting, the cells were serum-starved in the same media
but containing 0.5% FBS for 24–36 hr and treated with the indicated drugs/
compounds. The 24 hr starvation was only used in assays where treatment
time was 18–24 hr. For shorter treatment times (2–6 hr), a 36 hr starvation
was preferred to induce a rapid response.
In Vitro Phosphorylation
Myc-tagged Gli2/3 fragments were cloned into pCS2 and overexpressed in
HEK293T cells. In vitro phosphorylation was carried out on immunoprecipi-
tated proteins in the PKA reaction buffer (Promega) in the presence of
0.5 mM ATP, 10 mCi of [g-32P]ATP, and 21 U of PKA (NEB) for 30 min at
30C. See Supplemental Experimental Procedures for more details.
Hedgehog Reporter Luciferase Assay
The Hedgehog reporter luciferase assay was performed as described by us
before (Dorn et al., 2012). See Supplemental Experimental Procedures for
more details. All plots are mean ± SD.
Generation of Stable Cell Lines
Stable cell lines expressing low levels of HA-tagged Gli2 andGli3 variants were
generated using the Flp-In method exactly according to the manufacturer’s
recommendations (Life Technologies). Briefly, cells were cotransfected with
pOG44 and the pEF5/FRT/V5-DEST vector containing the Gli2/3 construct
of interest. After 2 days, the cells were reseeded at low density and the culture
media was supplemented with hygromycin for stable integrant selection.
Stable cell lines were reselected with hygromycin on every other passage to
preserve selection pressure and prevent silencing of the transgene.
Subcellular Fractionation
The method for subcellular fractionation has been described by us in detail
previously (Humke et al., 2010). Quantification of western blot bands was per-
formed using ImageJ. Percent of the Gli2/3 variant present in the nuclear frac-
tions was calculated for each sample by dividing the integrated band density
for the nuclear fraction by the sum of densities for the cytoplasmic and nuclear
fraction of the same sample.
In Ovo Electroporation and Immunohistochemistry/In Situ
Hybridization of Chick tissue
HH stage 10–12 chick embryos were electroporated as previously described
(Novitch et al., 2001) and incubated for 48 hr to HH stages 20–22. See Sup-
plemental Experimental Procedures for detailed methods of tissue staining
and a list of reagents used.
Selected Reaction Monitoring Mass Spectrometry
Cells from two to six confluent 150 mm tissue culture dishes were serum-
starved for 36 hr and treated for indicated times with SAG and/or IBMX +CFSK. Bortezomib (1 mM) was added 4 hr prior to harvesting unless indicated
otherwise. The cell lysate was collected under denaturing conditions and
then diluted in RIPA buffer for immunoprecipitation. Endogenous Gli2 was
immunoprecipitated and the eluted protein was resolved using SDS-PAGE.
The gel fragment containing Gli2 was excised and trypsinized. Tryptic frag-
ments were extracted from the gel, purified using Oasis mElution columns,
and loaded onto a nano high-performance liquid chromatography system for
separation and MS analysis (Abell et al., 2011). See Supplemental Experi-
mental Procedures for more details regarding protein harvesting, purification,
and SRM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Discussion, Supplemental
Experimental Procedures, six figures, and one table and can be found with
this article online at http://dx.doi.org/10.1016/j.celrep.2013.12.003.
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